Korytkova 2, 1000 Ljubljana
+386 1 543 7103
tajnistvo.patologija@mf.uni-lj.si
Osveži iskanje
Pregledni
Draškovič T, Zidar N, Hauptman N.
Circulating tumor DNA Methylation biomarkers for characterization and determination of the cancer origin in malignant liver tumors.
Cancers 2023; 15; 1-21.
6.6
Raziskovalni
Jerala M, Hauptman N, Kojc N, Zidar N.
Expression of fibrosis-related genes in liver and kidney fibrosis in comparison to inflammatory bowel diseases.
Cells 2022; 11; 1-13.
7.7
Prikaz primera
Pušnik L, Šekoranja D, Plut D.
A Unique Case of Multicentric Infantile Myofibromatosis with Radiologic-Pathologic Correlation.
. Children (Basel). 2022; 9:53.
2.8
Burja B, Hočevar A, Šekoranja D, Živec K, Rotar Ž, Shoenfeld Y, Praprotnik S.
PR3-ANCA vasculitis as manifestation of ASIA syndrome following aesthetic breast augmentation: a new kid on the block?
Clin Exp Rheumatol. 2022; 40:865-866.
4.8
Belak U, Pinter B, Ban Frangež H, Velikonja M, Korošec S.
Pathology of the Placenta in Singletons after Assisted Reprodustive Technology Compared to Singletons after Spontaneous Conception: A Systematic Review.
Fetal Pediatr Pathol 2022 Dec 29; 29: 1-12.
1.8
Sladic M, Taneska P, Cvjetićanin B, Velikonja M, Smrkolj V, Smrkolj Š.
Cervical Intraepithelial Neoplasia Grade 3 in a HPV-Vaccianted Patient: A Case Report.
Medicina 2022 Feb 23; 58(3): 339.
2.9
Tomic M, Bolha L, Pizem J, Ban-Frangez H, Vrtacnik-Bokal E, Stimpfel M.
Association between Sperm Morphology and Altered Sperm microRNA Expression.
Biology (Basel). 2022 Nov 17;11(11):1671.
5.2
Zupan M, Lavrič A, Pižem J, Andrejčič KN.
Iris Ring Melanoma Presenting as Scleral Pigmentation.
Case Rep Ophthalmol Med. 2022 Jul 4;2022:4840380.
0.7
Kropivšek L, Pižem J, Mavčič B.
Giant Cell Tumor of Bone Versus Tenosynovial Giant Cell Tumor – Similarities and Differences.
Int J Surg Pathol. 2022 Sep;30(6):596-605.
1.4
Djokic M, Hadzialjevic B, Luzar B, Trotovšek B.
Primary Hepatic Leiomyoma in a Healthy Middle-Aged Woman: Literature Review and Case Report.
Front Surg. 2021 Jun 14;8:691674.
2.1
Accessibility Tools